Gad Rennert Rennert

Prof. Dr. Gad Rennert Rennert

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
NPNikos Papadimitriou
Nikos Papadimitriou
NDNiki Dimou
Niki Dimou
KTKostas Tsilidis
Kostas Tsilidis
BBBarbara Banbury
Barbara Banbury
RMRichard M. Martin
Richard M. Martin
NMNeil Murphy
Neil Murphy
Physical activity has been associated with lower risks of breast and colorectal cancer in epidemiological studies; however, it is unknown if these associations are causal or confounded. In two-sample Mendelian randomisation analyses, using summary genetic data from the UK Biobank and GWA consortia, we found that a one standard deviation increment in average acceleration was associated with lower risks of breast cancer (odds ratio [OR]: 0.51, 95% confidence interval [CI]: 0.27 to 0.98, P-value = 0.04) and colorectal cancer (OR: 0.66, 95% CI: 0.48 to 0.90, P-value = 0.01). We found similar magnitude inverse associations for estrogen positive (ER+ve) breast cancer and for colon cancer. Our results support a potentially causal relationship between higher physical activity levels and lower risks of breast cancer and colorectal cancer. Based on these data, the promotion of physical activity is probably an effective strategy in the primary prevention of these commonly diagnosed cancers.

3 December 2018 in Nature Genetics
Verified
Journal Article
Open access
JHJeroen R. Huyghe
Jeroen R. Huyghe
SBStephanie A. Bien
Stephanie A. Bien
THTabitha A. Harrison
Tabitha A. Harrison
HKHyun Min Kang
Hyun Min Kang
SCSai Chen
Sai Chen
UPUlrike Peters
Ulrike Peters
To further dissect the genetic architecture of colorectal cancer (CRC), we performed whole-genome sequencing of 1,439 cases and 720 controls, imputed discovered sequence variants and Haplotype Reference Consortium panel variants into genome-wide association study data, and tested for association in 34,869 cases and 29,051 controls. Findings were followed up in an additional 23,262 cases and 38,296 controls. We discovered a strongly protective 0.3% frequency variant signal at CHD1. In a combined meta-analysis of 125,478 individuals, we identified 40 new independent signals at P < 5 × 10-8, bringing the number of known independent signals for CRC to ~100. New signals implicate lower-frequency variants, Krüppel-like factors, Hedgehog signaling, Hippo-YAP signaling, long noncoding RNAs and somatic drivers, and support a role for immune function. Heritability analyses suggest that CRC risk is highly polygenic, and larger, more comprehensive studies enabling rare variant analysis will improve understanding of biology underlying this risk and influence personalized screening strategies and drug development.

18 May 2020 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
HZHaoyu Zhang
Haoyu Zhang
TAThomas U. Ahearn
Thomas U. Ahearn
JLJulie Lecarpentier
Julie Lecarpentier
JBJonathan Beesley
Jonathan Beesley
GQGuanghao Qi
Guanghao Qi
MGMontserrat García-Closas
Montserrat García-Closas

12 July 2007 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
GRGad Rennert Rennert
Gad Rennert Rennert
SBShantih Bisland-Naggan
Shantih Bisland-Naggan
OBOfra Barnett-Griness
Ofra Barnett-Griness
NBNaomi Bar-Joseph
Naomi Bar-Joseph
SZShiyu Zhang
Shiyu Zhang
SNSteven A. Narod
Steven A. Narod
Some features of breast cancer in women with a BRCA1 mutation suggest that hereditary breast cancer has a poor outcome. We conducted a national population-based study of Israeli women to determine the influence, if any, of a BRCA1 or a BRCA2 mutation on the prognosis in breast cancer.

20 December 2022 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
Ceres Fernández-RozadillaCeres Fernández-Rozadilla
Ceres Fernández-Rozadilla
MTMaria Timofeeva
Maria Timofeeva
ZCZhishan Chen
Zhishan Chen
PLPhilip Law
Philip Law
MTMinta Thomas
Minta Thomas
UPUlrike Peters
Ulrike Peters

18 June 2018 in Nature Genetics
Verified
Journal Article
Open access
PDF file
NCNbcs Collaborators
Nbcs Collaborators
LWLang Wu
Lang Wu
KIkConFab/AOCS Investigators
kConFab/AOCS Investigators
WSWei Shi
Wei Shi
JLJirong Long
Jirong Long
WZWei Zheng
Wei Zheng
The breast cancer risk variants identified in genome-wide association studies explain only a small fraction of the familial relative risk, and the genes responsible for these associations remain largely unknown. To identify novel risk loci and likely causal genes, we performed a transcriptome-wide association study evaluating associations of genetically predicted gene expression with breast cancer risk in 122,977 cases and 105,974 controls of European ancestry. We used data from the Genotype-Tissue Expression Project to establish genetic models to predict gene expression in breast tissue and evaluated model performance using data from The Cancer Genome Atlas. Of the 8,597 genes evaluated, significant associations were identified for 48 at a Bonferroni-corrected threshold of P < 5.82 × 10−6, including 14 genes at loci not yet reported for breast cancer. We silenced 13 genes and showed an effect for 11 on cell proliferation and/or colony-forming efficiency. Our study provides new insights into breast cancer genetics and biology.